{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:05:23Z","timestamp":1790874323805,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":150,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["gimopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine Open"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.gimo.2024.101856","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T20:12:10Z","timestamp":1721074330000},"page":"101856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)"],"prefix":"10.1016","volume":"2","author":[{"given":"Pavalan","family":"Selvam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.","family":"Mares Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuntal","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Morales Corado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gimo.2024.101856_bib1","series-title":"StatPearls [internet]","article-title":"Rett syndrome","author":"Chahil","year":"2023"},{"issue":"8","key":"10.1016\/j.gimo.2024.101856_bib2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/humu.23263","article-title":"RettBASE: Rett syndrome database update","volume":"38","author":"Krishnaraj","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.gimo.2024.101856_bib3","series-title":"GeneReviews [internet]","article-title":"MECP2 disorders","author":"Kaur","year":"2019"},{"issue":"1","key":"10.1016\/j.gimo.2024.101856_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajmg.b.32707","article-title":"The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2","volume":"180","author":"Neul","year":"2019","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.gimo.2024.101856_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neubiorev.2019.07.005","article-title":"Can Rett syndrome be diagnosed before regression?","volume":"104","author":"Neul","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.gimo.2024.101856_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2020-000717","article-title":"Consensus guidelines on managing Rett syndrome across the lifespan","volume":"4","author":"Fu","year":"2020","journal-title":"BMJ Paediatr Open"},{"issue":"7","key":"10.1016\/j.gimo.2024.101856_bib7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/dmcn.14419","article-title":"Serial follow-up of corrected QT interval in Rett syndrome","volume":"62","author":"Clark","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"10.1016\/j.gimo.2024.101856_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/acschemneuro.2c00675","article-title":"Concise overview of glypromate neuropeptide research: from chemistry to pharmacological applications in neurosciences","volume":"14","author":"Silva-Reis","year":"2023","journal-title":"ACS Chem Neurosci"},{"issue":"15","key":"10.1016\/j.gimo.2024.101856_bib9","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.3390\/jcm12155114","article-title":"Trofinetide for Rett syndrome: highlights on the development and related inventions of the first USFDA-approved treatment for rare pediatric unmet medical need","volume":"12","author":"Hudu","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.gimo.2024.101856_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5582\/irdr.2023.01060","article-title":"Trofinetide in Rett syndrome: a brief review of safety and efficacy","volume":"12","author":"Singh","year":"2023","journal-title":"Intractable Rare Dis Res"},{"issue":"10","key":"10.1016\/j.gimo.2024.101856_bib12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.tips.2023.06.008","article-title":"Trofinetide: a pioneering treatment for Rett syndrome","volume":"44","author":"Parent","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.gimo.2024.101856_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2017.07.002","article-title":"A\u00a0double-blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of Rett syndrome","volume":"76","author":"Glaze","year":"2017","journal-title":"Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.gimo.2024.101856_bib14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","article-title":"Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study","volume":"29","author":"Neul","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.gimo.2024.101856_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pediatrneurol.2023.11.005","article-title":"Trofinetide treatment demonstrates a benefit over placebo for the ability to communicate in Rett syndrome","volume":"152","author":"Neul","year":"2024","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.gimo.2024.101856_bib16","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s12325-024-02782-4","article-title":"Managing gastrointestinal symptoms resulting from treatment with trofinetide for Rett syndrome: caregiver and nurse perspectives","volume":"41","author":"Moore","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.gimo.2024.101856_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2020.04.019","article-title":"A\u00a0double-blind, randomized, placebo-controlled clinical study of trofinetide in the treatment of fragile X syndrome","volume":"110","author":"Berry-Kravis","year":"2020","journal-title":"Pediatr Neurol"}],"container-title":["Genetics in Medicine Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774424010021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949774424010021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T09:10:41Z","timestamp":1735290641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949774424010021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":16,"alternative-id":["S2949774424010021"],"URL":"https:\/\/doi.org\/10.1016\/j.gimo.2024.101856","relation":{},"ISSN":["2949-7744"],"issn-type":[{"value":"2949-7744","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gimo.2024.101856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"101856"}}